Therapeutic effects of anti-spastic medication on neuromuscular abnormalities in SCI: A system identification approach

Proceedings of the Annual International Conference of the IEEE Engineering in Medicine and Biology Society, EMBS

Volumn , Issue , 2013, Pages 6203-6206

  Mirbagheri, M M ^a,b   Kindig, M ^b   Niu, X ^a,b   Varoqui, D ^a,b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b REHABILITATION INSTITUTE OF CHICAGO   (United States)

Author keywords

ankle; identification; intervention; medication; neuromuscular; reflex; spasticity; spinal cord injury; stiffness; tizanidine

Indexed keywords

ANKLE; INTERVENTION; MEDICATION; NEUROMUSCULAR; REFLEX; SPASTICITY; SPINAL CORD INJURIES (SCI); TIZANIDINE;

BINARY SEQUENCES; IDENTIFICATION (CONTROL SYSTEMS); STIFFNESS;

PATIENT REHABILITATION;

ANTICONVULSIVE AGENT; CLONIDINE; TIZANIDINE;

ALGORITHM; ANALOGS AND DERIVATIVES; ANKLE; ELECTROMYOGRAPHY; HUMAN; JOINT CHARACTERISTICS AND FUNCTIONS; KINESIOTHERAPY; MUSCLE SPASTICITY; PATHOPHYSIOLOGY; PHYSIOLOGY; RANDOMIZATION; REFLEX; ROBOTICS; SPINAL CORD INJURIES;

ALGORITHMS; ANKLE; ANKLE JOINT; ANTICONVULSANTS; CLONIDINE; ELECTROMYOGRAPHY; EXERCISE THERAPY; HUMANS; MUSCLE SPASTICITY; RANDOM ALLOCATION; RANGE OF MOTION, ARTICULAR; REFLEX; ROBOTICS; SPINAL CORD INJURIES;

EID: 84886530839     PISSN: 1557170X     EISSN: None     Source Type: Conference Proceeding    
DOI: 10.1109/EMBC.2013.6610970     Document Type: Conference Paper

References (25)

1. R. Becker, O. Alberti, and B. L. Bauer, "Continuous intrathecal baclofen infusion in severe spasticity after traumatic or hypoxic brain injury, " J Neuorl, vol. 244, pp. 160-166, 1997.
2. F. M. Maynard, R. S. Karunas, and W. P. Waring, 3rd, "Epidemiology of spasticity following traumatic spinal cord injury, " Arch Phys Med Rehabil, vol. 71, pp. 566-9, Jul 1990.
3. J. W. Lance, "The control of muscle tone, reflexes, and movement: Robert Wartenberg Lecture, " Neurology, vol. 30, pp. 1303-13, Dec 1980.
4. E. Knutsson, A. Martensson, and L. Gransberg, "Antiparetic and antispastic effects induced by tizanidine in patients with spastic paresis, " J Neurol Sci, vol. 53, pp. 187-204, Feb 1982.
5. P. Delwaide, "Electrophysiological testing of spastic patients: its potential usefulness and limitations, " in Clinical Neurophysiology in Spasticity: Contribution to Assessment and Pathophysiology, Delwaide PJ and Young RR, Eds., ed Amsterdam: Elsvier, 1985, pp. 185-203.
6. M. Emre, "Review of clinical trials with tizanidine (Sirdalud), " in Spasticity: The current status of reserach and treatment, M. Emre and R. Benecke, Eds., ed Lancashire, UK: Parthenon, 1989, pp. 153-184.
7. C. J. Mathias, J. Luckitt, P. Desai, and et al., "Pharmacodynamics and pharmacokinetics of the oral antispastic agent tizanidine in patients with spinal cord injury, " J Rehabil Res Dev, vol. 26, pp. 9-16, 1989.
8. P. W. Nance, J. Bugaresti, K. Shellenberger, W. Sheremata, and A. Martinez-Arizala, "Efficacy and safety of tizanidine in the treatment of spasticity in patients with spinal cord injury. North American Tizanidine Study Group, " Neurology, vol. 44, pp. S44-51; discussion S51-2, Nov 1994.
9. M. M. Mirbagheri, D. Chen, and W. Z. Rymer, "Quantification of the effects of an alpha-2 adrenergic agonist on reflex properties in spinal cord injury using a system identification technique, " Journal of Neuroengineering and Rehabilitation, vol. 7, pp. -, Jun 23 2010.
10. E. Maupas, P. Marque, C. F. Roques, and M. Simonetta-Moreau, "Modulation of the transmission in group II heteronymous pathways by tizanidine in spastic hemiplegic patients, " J Neurol Neurosurg Psychiatry, vol. 75, pp. 130-5, Jan 2004.
11. A. J. Wagstaff and H. M. Bryson, "Tizanidine. A review of its pharmacology, clinical efficacy and tolerability in the management of spasticity associated with cerebral and spinal disorders, " Drugs, vol. 53, pp. 435-452, 1997.
12. B. Ashworth, "Preliminary trial of carisoprodol in multiple sclerosis, " Practitioner, vol. 192, pp. 540-542, 1964.
13. R. W. Bohannon and M. B. Smith, "Interrater reliability on a modified Ashworth scale of muscle spasticity, " Phys Ther, vol. 67, pp. 206-207, 1987.
14. B. Kollen, I. van de Port, E. Lindeman, J. Twisk, and G. Kwakkel, "Predicting improvement in gait after stroke. A longitudinal prospective study, " Stroke, vol. 36, pp. 2676-2680, 2005.
15. Kearney RE and Hunter IW, "Nonlinear identification of stretch reflex dynamics, " J Ann Biomed Eng, vol. 16, pp. 79-94, 1988.
16. Mirbagheri MM, Barbeau H, and Kearney RE, "Intrinsic and reflex contributions to human ankle stiffness: Variation with activation level and position, " Exp Brain Res, vol. 135, pp. 423-436, 2000.
17. M. M. Mirbagheri, X. Niu, M. Kindig, and D. Varoqui, "The effects of locomotor training with a robotic-gait orthosis (Lokomat) on neuromuscular properties in persons with chronic SCI, " in Engineering in Medicine and Biology Society (EMBC), 2012 Annual International Conference of the IEEE, 2012, pp. 3854-3857.
18. D. M. Coward, "Tizanidine: Neuropharmacology and mechanism of action, " Neurol, vol. 44 (suppl 9), pp. S6-S11, 1994.
19. P. J. Delwaide and G. Pennisi, "Tizanidine and electrophysiologic analysis of spinal control mechanisms in humans with spasticity, " Neurol, vol. 44 (suppl 9), pp. S21-S28, 1994.
20. A. Farina, A. Sekizawa, S. J. Ralston, M. E. D'Alton, and D. W. Bianchi, "Latent class analysis applied to patterns of fetal sonographic abnormalities: definition of phenotypes associated with aneuploidy, " Prenat Diagn, vol. 19, pp. 840-5, Sep 1999.
21. B. Muthen and L. K. Muthen, "Integrating person-centered and variable-centered analysis: growth mixtue modeling with latent trajectory classes, " Alcohol Clin Exp Res, vol. 24, pp. 882-91, 2000.
22. J. A. Hagenaars and A. L. McCutcheon, Applied latent class analysis. Cambridge; New York: Cambridge University Press, 2002.
23. C. Proust-Lima, L. Leternneur, and H. Jacqmin-Gadda, "A nonlinear latent class model for joint analysis of multivariate longitudinal data and a binary outcome, " Stat Med, vol. 26, pp. 2229-2245, 2006.
24. T. Jung and K. A. S. Wickrama, "An introduction to latent class growth analysis and growth mixture modeling, " Social and Personality Psychology Compass, vol. 2, pp. 302-317, Jan 2008.
25. S. A. Hardy and C. Thiels, "Using latent growth curve modeling in clinical treatment research: An example comparing guided self-change and cognitive behavioral therapy treatments for bulimia nervosa, " International Journal of Clinical and Health Psychology, vol. 9, pp. 51-71, Jan 2009.